Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-137' Or cancer = '' Total: 55 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-137 anaplastic astrocytoma down miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-137 astrocytoma down miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.
hsa-mir-137 bladder cancer up MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3.
hsa-mir-137 colon cancer down miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4.
hsa-mir-137 colorectal cancer down Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.
hsa-mir-137 colorectal cancer down MicroRNA-137, an HMGA1 Target, Suppresses Colorectal Cancer Cell Invasion and Metastasis in Mice by Directly Targeting FMNL2.
hsa-mir-137 colorectal cancer down Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
hsa-mir-137 colorectal cancer down Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.
hsa-mir-137 endometrial cancer down miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation.
hsa-mir-137 gastric cancer down miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.
hsa-mir-137 gastric cancer down miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.
hsa-mir-137 gastric cancer down Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.
hsa-mir-137 glioblastoma down miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
hsa-mir-137 glioblastoma down PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
hsa-mir-137 glioblastoma down miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.
hsa-mir-137 glioblastoma down MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
hsa-mir-137 glioblastoma down Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
hsa-mir-137 glioblastoma down MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2.
hsa-mir-137 glioblastoma down Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells.
hsa-mir-137 glioblastoma down Circulating microRNA-137 is a potential biomarker for human glioblastoma.
hsa-mir-137 glioma down Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1.
hsa-mir-137 glioma down Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137.
hsa-mir-137 hepatocellular carcinoma down FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.
hsa-mir-137 hepatocellular carcinoma down MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
hsa-mir-137 hepatocellular carcinoma up Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma.
hsa-mir-137 hepatocellular carcinoma down EDIL3 is a novel regulator of epithelial mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
hsa-mir-137 lung cancer down MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.
hsa-mir-137 lung cancer up Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
hsa-mir-137 lung cancer down Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
hsa-mir-137 malignant melanoma down miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
hsa-mir-137 malignant melanoma down Mechanism of miR-137 regulating migration and invasion of melanoma cells by targeting PIK3R3 gene.
hsa-mir-137 malignant melanoma down miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
hsa-mir-137 malignant melanoma down Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma.
hsa-mir-137 malignant melanoma up miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.
hsa-mir-137 malignant melanoma down miR-137 inhibits melanoma cell proliferation through downregulation of GLO1.
hsa-mir-137 multiple myeloma down miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
hsa-mir-137 multiple myeloma down miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF.
hsa-mir-137 neuroblastoma down MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.
hsa-mir-137 non-small cell lung cancer down MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells.
hsa-mir-137 non-small cell lung cancer down miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.
hsa-mir-137 non-small cell lung cancer down microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.
hsa-mir-137 non-small cell lung cancer down Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer.
hsa-mir-137 oral squamous cell carcinoma down Expression of MiRNA-137 in oral squamous cell carcinoma and its clinical significance.
hsa-mir-137 osteosarcoma down MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6.
hsa-mir-137 ovarian cancer down MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells.
hsa-mir-137 ovarian cancer down MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
hsa-mir-137 ovarian cancer down microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
hsa-mir-137 ovarian cancer down miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1.
hsa-mir-137 pancreatic cancer down MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP.
hsa-mir-137 papillary thyroid carcinoma down miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
hsa-mir-137 renal cell carcinoma down miR-137 inhibits renal cell carcinoma growth in vitro and in vivo.
hsa-mir-137 renal clear cell carcinoma down MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma.
hsa-mir-137 squamous carcinoma up MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.
hsa-mir-137 thyroid cancer down microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR.
hsa-mir-137 uveal melanoma down Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.